The incidence and influence factors of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients
10.3969/j.issn.1671-8283.2024.12.004
- VernacularTitle:骨肿瘤化疗患者中重度癌因性疲乏发生状况及其影响因素分析
- Author:
Guolin FANG
1
;
Changli WAN
1
;
Xiaolin LI
1
;
Yixuan OU
1
Author Information
1. 海军军医大学第二附属医院骨肿瘤科,上海,200003
- Publication Type:Journal Article
- Keywords:
bone tumour;
chemotherapy;
cancer related fatigue;
moderate to severe;
influence factor;
cross-sectional study
- From:
Modern Clinical Nursing
2024;23(12):23-28
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the incidence of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients and its influence factors were analyzed.Methods Totally 265 bone tumor chemotherapy patients who received chemotherapy for the first time in our hospital from January 2021 to June 2023 were selected as the research subjects by convenience sampling method.A general information survey Hamilton anxiety scale,Hamilton depression scale,simplified coping style questionnaire and the Piper fatigue scale revised(PFS-R)were used to investigate the cancer-related fatigue status of bone tumor chemotherapy patients,and the logistic regression analysis was used to analyze its influencing factors.Results Totally 239 patients completed the study.Among 239 bone tumor chemotherapy patients,154 cases had moderate to severe cancer-related fatigue,the incidence rate was 64.44%.The Logistic regression analysis showed that daily sleep time<5 hours,low body weight,and high anxiety and depression scores were risk factors for moderate to severe cancer-related fatigue in bone tumor chemotherapy patients,while active coping strategies was protective factors(all P<0.05).Conclusion The incidence of moderate to severe cancer-related fatigue in bone tumor chemotherapy patients is relatively high.Preintervention is needed for patients with low body weight,short sleep time,anxiety,depression,and negative coping strategies to reduce the occurrence of moderate to severe cancer-related fatigue in patients.
